The GPER1 agonist G1 reduces brain injury and improves the qEEG and behavioral outcome of experimental ischemic stroke

Ferreira, Luan Oliveira; Souza, Rafael Dias de; Teixeira, Leonan Lima; Pinto, Laine Celestino; Rodrigues, João Cleiton Martins; Martins Filho, Arnaldo Jorge; Costa, Edmar Tavares da; Hamoy, Moisés; Lopes, Dielly Catrina Favacho.
FERREIRA, Luan Oliveira et al. The GPER1 agonist G1 reduces brain injury and improves the qEEG and behavioral outcome of experimental ischemic stroke. Journal of Neuropathology & Experimental Neurology, v. 82, n. 9, p. 787-797, Sept. 2023. DOI: https://doi.org/10.1093/jnen/nlad061.
Artigo em Inglês | IED | ID: ied-6895

Documentos relacionados

  1. A Measure of Neural Function Provides Unique Insights into Behavioral Deficits in Acute Stroke.
  2. Themed series on neuropharmacology.
  3. Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.
  4. A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
  5. Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke.
  6. The neuropharmacology of social behavior: From bench to bedside.
  7. Data-Driven EEG Band Discovery with Decision Trees.
  8. Linear and Non-linear Analyses of EEG in a Group of ASD Children During Resting State Condition.
  9. A neurodynamic model of inter-brain coupling in the gamma band.
  10. The golden years: a tribute to Erminio Costa.